BMY - BRISTOL MYERS SQUIBB CO
60.28
0.470 0.780%
Share volume: 8,982,017
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$59.81
0.47
0.01%
Summary score
32%
Profitability
7%
Dept financing
49%
Liquidity
74%
Performance
42%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.19%
Return on assets
1.34%
Return on sales
11.19%
Return on invested capital
1.42%
Total debt ratio
71.3%
Debt ratio change over timeo
16.78%
Current Ratio
1.33%
Quick Ratio
1.22%
Cash Position Ratio
0.49%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-31.18%
Return on assets
-0.79%
Return on sales
-6.17%
Return on invested capital
-11.48%
Total debt ratio
82.47%
Debt ratio change over timeo
14.84%
Current Ratio
1.17%
Quick Ratio
1.05%
Cash Position Ratio
0.35%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0.19%
Return on sales
3.89%
Return on invested capital
0%
Total debt ratio
82.36%
Debt ratio change over time
0%
Current Ratio
1.25%
Quick Ratio
1.15%
Cash Position Ratio
0.44%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-78.99%
Return on assets
-62.98%
Return on sales
210.14%
Return on invested capital
-58.5%
Total debt ratio
1677.56%
Debt ratio change over time
16.78%
Current Ratio
33.5%
Quick Ratio
30.64%
Cash Position Ratio
12.48%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BMY | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0.19% | 15.71% | 0% | 0% |
| Return on assets | 1.34% | 4.24% | 0% | 0% |
| Return on sales | 11.19% | 28.08% | 0% | 0% |
| Return on invested capital | 1.42% | 9.78% | 0% | 0% |
| Profitability | 22% | 100% | 0% | 0% |
| Total debt ratio | 71.3% | 81.31% | 0% | 0% |
| Debt ratio change over time | 16.78% | -15.58% | 0% | 0% |
| Dept financing | 47% | 25% | 0% | 0% |
| Current Ratio | 1.17% | 1.25% | 0% | 0% |
| Quick Ratio | 1.05% | 0.96% | 0% | 0% |
| Cash Position Ratio | 0.35% | 0.13% | 0% | 0% |
| Liquididy | 75% | 49% | 0% | 0% |
| Short-term ratios | BMY | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | -31.18% | 17.51% | 0% | 0% |
| Return on assets | -0.79% | 4.29% | 0% | 0% |
| Return on sales | -6.17% | 28.55% | 0% | 0% |
| Return on invested capital | -11.48% | 11.13% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 82.47% | 80.84% | 0% | 0% |
| Debt ratio change over time | 14.84% | 4.11% | 0% | 0% |
| Dept financing | 50% | 31% | 0% | 0% |
| Current Ratio | 1.17% | 1.25% | 0% | 0% |
| Quick Ratio | 1.05% | 0.96% | 0% | 0% |
| Cash Position Ratio | 0.35% | 0.13% | 0% | 0% |
| Liquididy | 73% | 57% | 0% | 0% |